Abstract
Thirty-seven patients with previously untreated invasive carcinoma of the uterine cervix, International Federation of Gynecology and Obstetrics (FIGO) stages IB to IVA, were treated with 4,000 rad external beam radiotherapy (EXRT) to midplane, followed by two intracavitary endocurietherapy (ECT) applications of 2,500 rad each to point “A” using a Kumar applicator, for a total dose of 9,000 rad. The major complication rate was 2.7 percent, and the local control rate was 85 percent (22/26 patients) for stages IB and II, and 91 percent (10/11 patients) for stages III and IVA. The three-year uncorrected observed actuarial survival was 80.3 percent for stages IB and II, and 81.8 percent for stages III and IVA. The three-year adjusted actuarial survival rate was 95.2 percent for stages IB and II, and 90.5 percent for stages III and IVA.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fletcher G. H. Clinical dose-response curve of subclinical aggregates of epithelial cells. J Radiol Electrol Med Nucl. 1972 Mar;53(3):201–206. [PubMed] [Google Scholar]
- Fletcher G. H. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer. 1972 Jun;29(6):1450–1454. doi: 10.1002/1097-0142(197206)29:6<1450::aid-cncr2820290605>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
- Fletcher G. H. Radiation and drug resistance of breast cancer. Am J Clin Oncol. 1984 Dec;7(6):617–624. doi: 10.1097/00000421-198412000-00007. [DOI] [PubMed] [Google Scholar]
- Hanks G. E., Herring D. F., Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer. 1983 Mar 1;51(5):959–967. doi: 10.1002/1097-0142(19830301)51:5<959::aid-cncr2820510533>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Kumar P. P., Good R. R., Cox T. A., Leibrock L. G., Skultety F. M. Reversal of visual impairment after interstitial irradiation of pituitary tumor. Neurosurgery. 1986 Jan;18(1):82–84. doi: 10.1227/00006123-198601000-00014. [DOI] [PubMed] [Google Scholar]
- Kumar P. P., Good R. R., Epstein B. E. Relationship of dose to local control in advanced stage III and IV head and neck cancer treated by surgery and postoperative radiotherapy. Am J Clin Oncol. 1987 Jun;10(3):240–242. doi: 10.1097/00000421-198706000-00015. [DOI] [PubMed] [Google Scholar]
- Kumar P. P., Good R. R. High-activity intraluminal 192iridium endocurietherapy for treatment of esophageal cancer. Radiat Med. 1986 Apr-Jun;4(2):54–59. [PubMed] [Google Scholar]
- Kumar P. P., Good R. R., McCaul G. F. Intraluminal endocurietherapy of inoperable Klatskin's tumor with high-activity 192iridium. Radiat Med. 1986 Jan-Mar;4(1):21–26. [PubMed] [Google Scholar]
- Kumar P. P., Good R. R., Skultety F. M., Leibrock L. G., Severson G. S. Radiation-induced neoplasms of the brain. Cancer. 1987 Apr 1;59(7):1274–1282. doi: 10.1002/1097-0142(19870401)59:7<1274::aid-cncr2820590708>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- Perez C. A., Breaux S., Bedwinek J. M., Madoc-Jones H., Camel H. M., Purdy J. A., Walz B. J. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer. 1984 Jul 15;54(2):235–246. doi: 10.1002/1097-0142(19840715)54:2<235::aid-cncr2820540210>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- Peters L. J., Fletcher G. H. Causes of failure of radiotherapy in head and neck cancer. Radiother Oncol. 1983 Aug;1(1):53–63. doi: 10.1016/s0167-8140(83)80007-3. [DOI] [PubMed] [Google Scholar]
- Puthawala A. A., Syed A. M., Gates T. C. Iridium-192 implants in the treatment of tonsillar region malignancies. Arch Otolaryngol. 1985 Dec;111(12):812–815. doi: 10.1001/archotol.1985.00800140056010. [DOI] [PubMed] [Google Scholar]